Low mitotic rates, clusters of hyalinized thin-walled ectatic vessels, and immunoreactivity for CD34 help differentiate PHAT from malignant fibrous histiocytoma. This evidence concerns the gene CD34 and undifferentiated pleomorphic sarcoma.